Rare species

Last summer 2011, Germany stumbled upon an outbreak of a rare species of E. coli O104:H4 (Pennington 2011). The causative strains appeared to have features from two different E. coli pathotypes of enteroaggregative E. coli (EAEC) and shiga-toxin-producing E. coli (STEC) called enterohaemorrhagic E. coli (EHEC) (Bloch, Felczykowska and Nejman-Faleńczyk 2012). The main effect from this strain causes major incident of gastroenteritis and unusual develop of haemolytic-uremic syndrome (HUS) among the

The “Nokshobli” Deep in the nearby swamps of a peaceful village, it was believed that there lived some mysterious creatures with magical powers. The locals called them “the Nokshobli” meaning odd people. These creatures were thought to be short in height of 2 feet and 4 feet tall. It is also believed that the Nokshobli is very powerful, with either light or dark forces. However, these creatures resemble a little man, but some describe them with scales and dark glowing red eyes. The eyes of the Nokshobli

Today baton performance is getting popular in Japan, we can watch it on the TV show or musical. Using a baton on the performance can make a wonderful musical stage and impress people. When I was from elementary school to high school, I was in team of baton. I have never forgot the last performance. This experience made me grew up in my life. One day I was watching a TV show about girls group who are singers using a baton. I thouhgt I want to do same things as girls because they looked so amazing

At age ten, Natalie Jonen went to her first baton-twirling camp. At the end of this camp, the counselor allowed the campers to twirl batons that were on fire. It was then that Natalie fell in love with baton and, later, fire baton. Since then, she has continued to twirl fire batons for Olympia High twirl competitively and thus has improved the hand-eye coordination necessary for both her sport and her ambition of becoming a surgeon. With the support of her father and older sister, Natalie aspires

I have been dedicated to the National Baton Twirling Association, NBTA, since the age of seven. For a whole decade I spent my time waking up early on Saturdays to be in the gym from 7AM to 3PM, wearing pageant dresses with heels higher than my GPA and traveling extensive hours by car to competitions across the United States. To some this may sound completely insane, but no matter how much pain and stress twirling has brought upon me, I cannot help but fall more and more in love with the sport that

the Threatened and Endangered Species System (TESS) information, there are 599 endangered plants and 147 threatened plants in the US alone (TESS, 2004). These listings rely on a very stern legal system. Whether they can be labeled “rare”, “threatened,” or “endangered”, it is determined by the measure of endangerment the species sustain. An “endangered” type is one that is in jeopardy of extinction throughout all or a major fraction of its range. A “threatened” species is one that is likely to become

What is integrative studies? Integrative studies is the ability to form bridges between different areas of knowledge creating a network of information. Thus, allowing us to see each individual area in it’s own right but also how the areas do or do not function as a whole. A wonderful example of this would be a puzzle. Each individual piece is portraying a specific image or part of an image. Some puzzle pieces fit together while others do not. But once the puzzle is finished not only are you able

operations in Europe, South America, USA and Asia. BioMarin originally began developing carbohydrate enzymes for rare diseases. Their first candidate drug was Aldurazyme® which is currently being used to treat patients of Mucopolysaccharidosis (MPS-I). MPS-I patient census consists of about 3,400 patients in developed countries; 1,000 of which reside in the United States of America. Because of the rare nature of this condition and the rareness of other conditions being treated by BioMarin, they are considered

Since its inception in 1981, Genzyme, a biotechnology company, has pursued a path remarkably different from its peers: develop drugs for rare diseases rather than “blockbuster” drugs. The company continued to operate independently managing its own production, sales, and testing facilities rather than collaborating with large pharmaceutical companies. It went public in 1986, raising $27 million. By 2006, Genzyme was the world’s third-largest biotechnology company. In 2011, it was acquired by Sanofi

Jay Patel Genzyme’s CSR Dilemma: How to play its HAND 07-13-2015 Due: Thursday, 16th, 2015 BACKGROUND ABOUT THE COMPANY. Genzyme is an American Biotechnology party based in Cambridge, Massachusetts. Genzyme is third biggest biotechnology company with over 10,000 employees around the globe. it is located within over 65 countries. Genzyme has over revenues over $4.6 billion. Fun fact about the company I found was they had donated almost $100 million in 2006. The case talks about HAND which means